These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 15387973)
1. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene]. Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973 [TBL] [Abstract][Full Text] [Related]
2. [Intravenous delivery of cationic liposomes conjugation to recombinant adenoviral vectors containing human endostatin gene inhibits ovarian cancer growth in nude mice]. Wang L; Yang L; Wu YK; Zhao X; Wei YQ; Li W; Tian Q Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):190-4. PubMed ID: 19462887 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy using adenovirus-mediated full-length anti-HER-2 antibody for HER-2 overexpression cancers. Jiang M; Shi W; Zhang Q; Wang X; Guo M; Cui Z; Su C; Yang Q; Li Y; Sham J; Liu X; Wu M; Qian Q Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6179-85. PubMed ID: 17062695 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. McKenzie T; Liu Y; Fanale M; Swisher SG; Chada S; Hunt KK Surgery; 2004 Aug; 136(2):437-42. PubMed ID: 15300212 [TBL] [Abstract][Full Text] [Related]
5. HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model. Zhang Y; Yu D; Xia W; Hung MC Oncogene; 1995 May; 10(10):1947-54. PubMed ID: 7761095 [TBL] [Abstract][Full Text] [Related]
6. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]. Song Y; Shen K; Yu JR Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein. Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin]. Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284 [TBL] [Abstract][Full Text] [Related]
9. Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells. Bocangel D; Zheng M; Mhashilkar A; Liu Y; Ramesh R; Hunt KK; Chada S Cancer Gene Ther; 2006 Oct; 13(10):958-68. PubMed ID: 16783343 [TBL] [Abstract][Full Text] [Related]
10. [Adenovirus mediated angiostatin gene therapy for ovarian cancer: experiment with nude mice]. Jia CR; Yang SY; Han SY; Sun L Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2204-8. PubMed ID: 19080673 [TBL] [Abstract][Full Text] [Related]
11. Stable suppression of HER-2 gene expression using siRNA increases the lysis of human ovarian carcinoma cells mediated by NK-92 cell line. Zhou Y; Cheng Z; Zhu H; Feng D; Zhao W; Ling B; Wei H; Tian Z Oncol Rep; 2008 Dec; 20(6):1425-31. PubMed ID: 19020724 [TBL] [Abstract][Full Text] [Related]
12. Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells. Jung Y; Park HJ; Kim PH; Lee J; Hyung W; Yang J; Ko H; Sohn JH; Kim JH; Huh YM; Yun CO; Haam S J Control Release; 2007 Nov; 123(2):164-71. PubMed ID: 17854941 [TBL] [Abstract][Full Text] [Related]
13. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting]. Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus 5 E1a-mediated gene therapy for human ovarian cancer cells in vitro and in vivo. Zang RY; Shi DR; Lu HJ; Cai SM; Lu DR; Zhang YJ; Qin HL Int J Gynecol Cancer; 2001; 11(1):18-23. PubMed ID: 11285029 [TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice]. Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412 [TBL] [Abstract][Full Text] [Related]
16. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454 [TBL] [Abstract][Full Text] [Related]
17. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]. Song Y; Shen K; He CX Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518 [TBL] [Abstract][Full Text] [Related]
18. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. Agus DB; Scher HI; Higgins B; Fox WD; Heller G; Fazzari M; Cordon-Cardo C; Golde DW Cancer Res; 1999 Oct; 59(19):4761-4. PubMed ID: 10519379 [TBL] [Abstract][Full Text] [Related]
19. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16. Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231 [TBL] [Abstract][Full Text] [Related]
20. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma]. Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]